Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Our specialist services

Adaptive Phase I & II
Adaptive Phase III
TQT Studies
Bridging Studies
Patient Recruitment
Data Management
Gene Editing & Gene Silencing
Regulatory Strategy Services
Pharmacovigilance

サービス一覧

適応的第I相・第II相試験
適応的第III相試験
TQT試験（心電図QT間隔評価試験）
ブリッジング試験
被験者リクルートメント
データマネジメント
遺伝子編集・遺伝子サイレンシング
規制戦略サービス
ファーマコビジランス
YOU ARE HERE: HOME > NEWS

Officially an ILS Resuscitation Council Course Centre

7
March 2018

View Articles

Dr Jorg Taubel attending ACCP in San Diego

5
September 2017

View Articles

DIA, Chicago 2017

23
June 2017

View Articles

Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

28
April 2017

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

View Articles

New CRO unit facility welcomes first overnight patients

31
March 2017

Richmond Pharmacology has been busy settling in their first patients at the new London Bridge site.

View Articles

Richmond Pharmacology Opens New London Bridge Site

3
March 2017

This decision marks the next step in Richmond Pharmacology’s continued growth, having already conducted over 300 studies in London since 2001, often in rare disease areas such as amyloidosis.

View Articles

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Careers at Richmond

We are on the lookout for people who love what they do, strive for excellence and who want to make a difference.

Our Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology

December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
© 2025 Richmond Pharmacology - all rights reserved
Disclaimer
|
Sitemap
|
Privacy Policy
|
Report A Concern
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesRejectAccept